Furthermore, Yang et al. have studied a cohort of head and neck tumors with low mutational burden and minimal immune infiltration, and identified gene-fusion derived neoantigens, e.g., the in-frame DEK–AFF2 gene fusion, that generate cytotoxic T cell responses [22]. This evidence concerns the gene DEK and head and neck neoplasm.